Protara Therapeutics, Inc. (TARA) Tops Q3 EPS by 2c

Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q3 EPS of ($0.50), $0.02 better than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.

You May Also Be Interested In

• Deere conference call: 2027 orders up mid-single digits from last year)
• Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth